Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
14.27
-0.35 (-2.39%)
Nov 21, 2024, 2:54 PM EST - Market open
Arcus Biosciences Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Arcus Biosciences stock have an average target of 34.5, with a low estimate of 20 and a high estimate of 50. The average target predicts an increase of 141.77% from the current stock price of 14.27.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for RCUS stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 4 | 5 | 5 | 5 | 6 | 6 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +40.15% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $25 → $29 | Buy | Maintains | $25 → $29 | +103.22% | Oct 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +40.15% | Oct 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $20 | Hold | Initiates | $20 | +40.15% | Oct 21, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $29 | Buy | Initiates | $29 | +103.22% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
249.18M
from 117.00M
Increased by 112.97%
Revenue Next Year
210.84M
from 249.18M
Decreased by -15.39%
EPS This Year
-3.38
from -4.15
EPS Next Year
-4.31
from -3.38
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 285.6M | 606.2M | 540.8M | ||
| Avg | 249.2M | 210.8M | 229.3M | ||
| Low | 111.7M | 29.4M | 88.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 144.1% | 143.3% | 156.5% | ||
| Avg | 113.0% | -15.4% | 8.8% | ||
| Low | -4.5% | -88.2% | -58.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.74 | -0.15 | -1.93 | ||
| Avg | -3.38 | -4.31 | -4.22 | ||
| Low | -4.06 | -6.60 | -6.08 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.